semaglutide and the heart Long-Term SELECT Trial: Cuts Cardiovascular Events by 20% beyond Weight Loss SELECT Trial

CuiMHongYHuangJLiuKChenJTanYet al

Finally, GLP-1R and NPY2R activation can also improve stroke recovery through acute neuroprotection if they are given acutely after stroke, independently of their metabolic effects

Participants experienced an average weight loss of 10-15% of their body weight over 68 weeks when using semaglutide alongside a healthy diet and exercise regimen

These drugs demonstrate potential therapeutic value through modulation of GSTM1 expression or the oxidative stress pathway

Dispose of used needles and vials properly

Tirzepatide: What the Human Evidence Actually Shows Tirzepatides evidence base is the kind that supports an approval: large, completed, randomised Phase 3 trials with active and placebo comparators